Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study

Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study

Cholangiocarcinoma (CCA) is a highly lethal disease because most patients are asymptomatic until they progress to advanced stages. Current CCA diagnosis relies on clinical imaging tests and tissue biopsy, while specific CCA biomarkers are still lacking. This study employed a translational proteomic...

Full description

Bibliographic Details
Main Authors: Kamolwan Watcharatanyatip, Somchai Chutipongtanate, Daranee Chokchaichamnankit, Churat Weeraphan, Kanokwan Mingkwan, Virat Luevisadpibul, David S. Newburg, Ardythe L. Morrow, Jisnuson Svasti, Chantragan Srisomsap
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Molecules
Subjects:
biomarker
cholangiocarcinoma
immunoassay
machine learning
multiplex assay
plasma proteomics
Online Access:https://www.mdpi.com/1420-3049/27/18/5904

Similar Items

Similar Items